Developmental and Behavioral Pediatrics

  • Research Faculty

  • Show All

    Director

    Faculty

    A photo of Julia Anixt.

    Julia S. Anixt, MD Pediatrician, Developmental and Behavioral Pediatrics

    is a developmental-behavioral pediatrician conducting clinical research on Attention Deficit/ Hyperactivity Disorder (ADHD). In particular her work focuses on improving the quality of care for ADHD diagnosis and treatment for children in underserved communities and assessing the impact of parent and youth perceptions about ADHD on treatment decisions.

    513-636-4611
    julia.anixt@cchmc.org

    Julia S. Anixt, MD

    Pediatrician, Developmental and Behavioral Pediatrics

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4611

    Fax: 513-636-3800

    Email: julia.anixt@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Attention Deficit / Hyperactivity Disorder (ADHD); Autism Spectrum Disorders (ASD); learning difficulties; developmental and behavioral issues in underserved populations; developmental outcomes in children with congenital heart disease

    Research Interests

    ADHD; use of shared decision making for the treatment of challenging behavior in children with ASD; the diagnosis and management of behavioral and mental health issues in primary care settings; access to care for underserved populations

    Biography

    Julia Anixt, MD, is a developmental-behavioral pediatrician conducting clinical research on Attention Deficit/ Hyperactivity Disorder (ADHD).  In particular her work focuses on improving the quality of care for ADHD diagnosis and treatment for children in underserved communities and assessing the impact of parent and youth perceptions about ADHD on treatment decisions.  Her research also focuses on implementing Shared Decision Making (SDM) in the clinical setting for families of children with Autism Spectrum Disorders (ASD) contemplating the use of medication to target challenging behaviors.

    Education and Training

    MD: University of Maryland School of Medicine, Baltimore, MD, 2001.

    Residency: Pediatrics, Yale New-Haven Hospital, New Haven, CT, 2004.

    Fellowship: Robert Wood Johnson Clinical Scholars Program, Johns Hopkins University, Baltimore, MD, 2006. Developmental-Behavioral Pediatrics, University of Maryland, Baltimore, MD, 2008.

    Certification: General Pediatrics, American Board of Pediatrics, 2004; Developmental and Behavioral Pediatrics, American Board of Pediatrics, 2011.

    Publications

    View PubMed Publications

    Grants

    Interventions for children with Attention and Reading Disorders. Co-Investigator. National Institutes of Health. Dec 2009-Nov 2014. R01 HD060617.
    DefaultUserSmall

    Holly D. Barnard, PhD Neuropsychologist, Division of Developmental and Behavioral Pediatrics

    is a neuropsychologist whose research efforts have focused on neuropsychological sequelae of neurodevelopmental disorders and the interplay of genes and the environment in the manifestation of symptoms. Dr. Barnard is currently focused on projects exploring social interactions of children with ASDs and the impact of environmental risk factors (e.g., maternal cotinine levels) on the manifestation of executive dysfunction.

    513-636-4100
    holly.barnard@cchmc.org

    Holly D. Barnard, PhD

    Neuropsychologist, Division of Developmental and Behavioral Pediatrics

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-4100

    Email: holly.barnard@cchmc.org

    Show All

    Specialties

    Pediatric neuropsychology; autism spectrum disorders

    Biography

    Dr. Barnard completed her PhD in clinical psychology at the University of Denver, where she was awarded a National Research Service Awards (NRSA) from the National Institute of Mental Health (NIMH) to study gene-environment interactions in the manifestation of Attention-Deficit Hyperactivity Disorder (ADHD). She went on to complete her internship and APPCN fellowship in pediatric neuropsychology at the University of Illinois at Chicago Medical Center (UICMC), where she received broad-based training in both medical and developmental neuropsychology in children and pursued specialty training (site reliability in the administration and coding of the ADOS and ADI-R) in diagnostic assessment of Autism Spectrum Disorders (ASDs).

    Since being recruited to Cincinnati Children's, Dr. Barnard has co-founded the Developmental Neuropsychology Clinic (DNC), a doctoral-level practicum placement in pediatric neuropsychology, and currently supervises advanced doctoral students hailing from numerous programs around the Tristate area. Dr. Barnard and her team in the DNC evaluate patients who present with a wide variety of neurodevelopmental conditions, but Dr. Barnard continues to have a particular interest in ASDs and genetic/chromosomal disorders. Additionally, Dr. Barnard consults on numerous ongoing research projects, both through Cincinnati Children's and University of Cincinnati (UC), and serves as an active instructor in the doctoral program at UC.

    Education and Training

    BA: Neuroscience, Amherst College, Amherst, MA, 2001.

    PhD: Clinical Psychology, University of Denver, Denver, CO, 2009.

    Internship: Child Psychology, Institute for Juvenile Research; University of Illinois at Chicago Medical Center, Chicago, IL.

    Fellowship: Pediatric Neuropsychology, University of Illinois at Chicago Medical Center, Chicago, IL.

    Publications

    View PubMed Publications

    Grants

    Quantifying White Matter Degeneration Using DTI in Pediatric Populations with Hydrocephalus. Consulting Neuropsychologist. National Institute of Health. 2010 – Present.
    A photo of Amie Duncan.

    Amie W. Duncan, PhD

    is a clinical psychologist who researches the transition to adulthood in adolescents with autism spectrum disorders (ASD). Specifically, she is interested in identifying factors that may promote or impede an optimal outcome in adulthood for individuals with ASD. She is also developing an intervention to increase daily living skills and overall independence in adolescents with ASD.

    513-803-2416
    amie.duncan@cchmc.org

    Amie W. Duncan, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-2416

    Fax: 513-803-2416

    Email: amie.duncan@cchmc.org

    Show All

    Specialties

    Autism spectrum disorders; transition to adulthood in adolescents with autism

    Education and Training

    BS: University of Dayton, 2004.

    MA: University of Alabama, Tuscaloosa, AL, 2006.

    PhD: University of Alabama, 2009.

    Publications

    Grants

    Training Outpatient Clinicians to Deliver Cognitive Behavior Therapy to Children with Autism Spectrum Disorders. Site Principal Investigator. National Institute of Mental Health. Jul 2012 – Jun 2014.

    Evaluating the Time-Dependent Unfolding of Social Interactions in Children with Autism Spectrum Disorders. Site Principal Investigator. National Institutes of Health. Aug 2012 – Jul 2014.
    A photo of Anna Esbensen.

    Anna J. Esbensen, PhD

    is a clinical psychologist who studies the lifespan development and health care of individuals with Down syndrome. She also studies the mental health of individuals with intellectual disability.


    anna.esbensen@cchmc.org

    Anna J. Esbensen, PhD

    Academic Information

    Assistant Professor, UC Department of Pediatrics

    Fax: 513-636-1360

    Email: anna.esbensen@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Behavior management; depression

    Research Interests

    Lifespan development of down syndrome; health care of individuals with down syndrome; development of depressive symptomatology among individuals with intellectual disability

    Biography

    Anna Esbensen is an assistant professor of psychology in the Division of Developmental and Behavioral Pediatrics. She studies the lifespan development of individuals with Down syndrome and provides clinical services through the Thomas Center. She also studies the mental health of individuals with intellectual disability.

    Education and Training

    PhD: The Ohio State University, Columbus, OH, 2004.

    MA: The Ohio State University, Columbus, OH, 2001.

    BScH: Queen’s University, Kingston, ON, Canada, 1997.

    Publications

    View PubMed Publications
    A photo of Tanya E. Froehlich, MD.

    Tanya Elizabeth Froehlich, MD, MS, FAAP

    focuses on attention-deficit/hyperactivity disorder. She is working to identify genetic and phenotypic predictors of ADHD medication response, as well as studying the contribution of environmental exposures (e.g., lead, tobacco, and pesticides) to ADHD etiology. In addition, her prior publications and current projects investigate the prevalence of ADHD, ADHD medication use, and preschool psychotropic medication use. 

    513-636-4611
    tanya.froehlich@cchmc.org

    Tanya Elizabeth Froehlich, MD, MS, FAAP

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4611

    Fax: 513-636-4402

    Email: tanya.froehlich@cchmc.org

    Show All

    Specialties

    ADHD, learning disabilities.

    Biography

    Dr. Froehlich is a developmental-behavioral pediatrician who cares for school age children with learning and behavioral issues.  Her research has a special focus on attention-deficit/hyperactivity disorder (ADHD), and approaches the disorder from the vantage points of epidemiology, etiology, and treatment.  She conducted a study reporting the national prevalence of ADHD in U.S. children based on DSM-IV criteria (published in the Archives of Pediatrics and Adolescent Medicine) which showed that children from disadvantaged socioeconomic backgrounds were most likely to meet criteria for ADHD, yet least likely to receive consistent ADHD pharmacotherapy.  Interested in understanding why certain children (including those with low socioeconomic status) may be more vulnerable to ADHD than others, she also studies the contribution of environmental exposures to ADHD and their public health impact.   In Pediatrics, she published the first study to investigate the interactive effects of prenatal tobacco exposure and childhood lead exposure on ADHD and demonstrated that the association between poverty and ADHD is partially explained by the effects of these common environmental toxicants.  She has also examined possible gene-environment interactions and found that boys with specific dopamine-related genetic variants were particularly susceptible to the adverse effects of lead exposure on ADHD-related executive functioning (published in Biological Psychiatry). Dr. Froehlich continues to research environmental influences on ADHD as a co-investigator on a National Institute of Environmental Health Sciences R01 grant which is examining the effects of pyrethroid pesticide exposure on ADHD symptoms and executive functioning.     

    Dr. Froehlich’s research agenda also addresses ADHD treatment.  She is the recipient of a National Institute of Mental Health K23 Award aimed at identifying genetic and phenotypic predictors of ADHD medication response.  Recently, she authored a paper in the Journal of the American Academy of Child and Adolescent Psychiatry showing that individuals with the dopamine receptor D4 and dopamine transporter genotypes believed to confer lower susceptibility to ADHD had greater improvement in their hyperactive-impulsive symptoms with methylphenidate treatment than those with the “high risk” genetic variants.  She also coauthored a study on a novel genotyping assay for carboxylesterase 1 (CES1), the enzyme which metabolizes methylphenidate, and is currently undertaking a study on CES1 genetic variants’ effects on methylphenidate response. 

    Dr. Froehlich also enhances care for children with ADHD through teaching and other professional activities.  She has served as an invited speaker providing seminars for professionals and workshops for families in international, national, and regional forums.  Currently, Dr. Froehlich co-chairs the Society for Developmental and Behavioral Pediatrics ADHD Special Interest Group, and coordinates ADHD-related projects and educational seminars for the Society membership in this capacity.

    Education and Training

    BA:  East Asian Studies, Columbia University, 1992.

    MD: Yale University School of Medicine, 1999.

    MS: Epidemiology, University of Cincinnati, 2007.

    Pediatric Intern:  Children’s Hospital of Philadelphia, 1999-2000.

    Pediatric Resident:  Children’s Hospital of Philadelphia, 2000-2002.

    Fellowship: Developmental and Behavioral Pediatrics, Cincinnati Children’s Hospital, 2002-2005; General Pediatrics National Research Service Award Fellow, Cincinnati Children’s Hospital, 2004-2007.

    Publications

    View PubMed Publications

    Grants

    Medication Response in Children with Predominantly Inattentive Type ADHD.  Principal Investigator.  National Institute of Mental Health Career Development (K23).  2009-2014.

    Mechanisms of Pesticide-Induced Neurobehavioral Deficits:  Relevance to ADHD.  Co-Investigator.  National Institute of Environmental Health Sciences (R01).  2010-2013.

    A photo of Richard Gilman.

    Richard C. Gilman, PhD Psychologist, Division of Child and Adolescent Psychiatry

    is a licensed psychologist who conducts research on risk and resiliency factors in physical and mental health. His work focuses on how environmental factors such as schools, families, and peers, play an important role in psychological and social functioning.

    513-636-8172
    richard.gilman@cchmc.org

    Richard C. Gilman, PhD

    Psychologist, Division of Child and Adolescent Psychiatry

    Academic Information

    Professor, UC Department of Pediatrics

    Phone: 513-636-8172

    Email: richard.gilman@cchmc.org

    Show All

    Specialties

    Depression; anxiety; adjustment issues; learning issues 

    Biography

    Dr. Gilman is a fellow in the American Psychological Association (Division 16, school psychology) and a fellow in the International Society for Quality of Life Studies. He is the author of The Handbook of Positive Psychology in Schools (now undergoing its second revision), an associate editor of Behavioural Change and School Psychology Review, and he is on the editorial board of five academic journals. With over 80 peer-reviewed publications, books, and book chapters on risk/resiliency factors in child development, Dr. Gilman’s work has been formally recognized by the American Psychological Association.

    Education and Training

    PhD: University of South Carolina, Columbia, SC.

    Fellowship: Georgia State University Counseling Center, Atlanta, GA.

    Residency: Father Flanagan’s Boy’s Home (aka Boy’s Town), Boys Town, NE.

    Publications

    View PubMed Publications

    Grants

    Using SNA to Examine the Long-Term Outcomes of Socially Excluded Adolescents. Principal Investigator. NICHD. April 2012-March, 2014.

    Validating a program to enhance social learning and preventing early sexual activity among children in a high-risk setting. Co-Investigator. NIH/NICHD.  Jan. 2007- Jan. 2009.

    Self-Management of Type 1 Diabetes During Adolescence. NIDDK. Consultant. 201

    A photo of Dr. Manning-Courtney.

    Patricia Manning-Courtney, MD Co-Director, Division of Developmental and Behavioral Pediatrics

    is a developmental-behavioral pediatrician and director of The Kelly O'Leary Center for Autism Spectrum Disorders (TKOC). TKOC is a member of the Autism Treatment Network, a network sponsored by Autism Speaks, committed to improving the long-term care and treatment of individuals with autism spectrum disorders. Dr. Manning is also leading a project on the collection of biomaterials from individuals with ASD.

    513-636-4611
    patty.manning@cchmc.org

    Patricia Manning-Courtney, MD

    Co-Director, Division of Developmental and Behavioral Pediatrics

    Director, Kelly O'Leary Center

    Academic Information

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4611

    Fax: 513-636-3800

    Email: patty.manning@cchmc.org

    Show All

    Specialties

    Developmental pediatrics; autism/pervasive developmental disorder; fragile X syndrome

    Education and Training

    MD: University of Cincinnati, Cincinnati, Ohio, 1991.

    Residency: Children's Hospital Medical Center, Cincinnati, Ohio.

    Fellowship: Developmental Pediatrics, University Affiliated Cincinnati Center for Developmental Disorders.

    Certification: Pediatrics, 1994.
    A photo of Susan Wiley.

    Susan E. Wiley, MD Co-Director, Division of Developmental and Behavioral Medicine

    is a developmental-behavioral pediatrician whose research focus is on children who are deaf/hard of hearing with additional disabilities. She works in collaboration with the Ear and Hearing Center. She is involved in a multi-site study funded by the Office of Special Education Programs on children who are deaf-blind with cochlear implants and a regional study on deafness and cognition, funded by the Maternal and Child Health Bureau.

    513-636-4611
    susan.wiley@cchmc.org

    Susan E. Wiley, MD

    Co-Director, Division of Developmental and Behavioral Medicine

    Pediatrician, Division of Developmental and Behavioral Pediatrics

    Fellowship Director

    Academic Information

    UC Department of Pediatrics

    Adjunct Associate Professor

    Phone: 513-636-4611

    Fax: 513-636-3800

    Email: susan.wiley@cchmc.org

    Show All

    Specialties

    Clinical

    Sensory loss (deaf, hard of hearing, blind, low vision)

    Research

    Deafness associated with an additional disability

    Education and Training

    MD: University of Cincinnati, OH, 1994.

    Residency: Pediatrics, Children's Hospital Medical Center of Cincinnati, OH.

    Fellowship: Developmental Pediatrics, Cincinnati Center for Developmental Disorders, Cincinnati, OH.

    Certification: Pediatrics, 1997.

    Certification: Developmental-Behavioral Pediatrics, 2002.

    Publications

    View PubMed Publications